SL-28 drug page Clinical trials

Trials with SL-28

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
60Planned patients

Showing 1–1 of 1

SL-28 for Advanced Solid Tumours
Recruiting Phase 1 60 patients NCT07341737

Second Life Therapeutics is developing SL-28, an allogeneic, non-genetically modified cell-based therapy for the treatment of advanced solid tumours. The company has recently demonstrated a novel, non-genetic approach to modulate immune ce…

Australia Aug 2026 – Mar 2027 Interventional

Where the recruiting trials are